Tafamidis, sold under the brand names Vyndaqel and Vyndamax. It is a medication used to treat transthyretin-mediated amyloidosis. Reference standards of Tafamidis API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Tafamidis
Catalogue No.:PA 20 3150000
CAS :
Molecular Formula : C14H7Cl2NO3
Molecular Weight : 308.11
4-[(3,5-Dichlorobenzoyl)amino]-3-hydroxybenzoic Acid
Catalogue No.:PA 20 3151000
Molecular Formula : C14H9Cl2NO4
Molecular Weight : 326.13
2-(3-Chlorophenyl)benzo[d]oxazole-6-carboxylic Acid;
Catalogue No.:PA 20 3151002
Molecular Formula : C14H8ClNO3
Molecular Weight : 273.67
4-(3-Chlorobenzamido)-3-hydroxybenzoic Acid
Catalogue No.:PA 20 3151001
Molecular Formula : C14H10ClNO4
Molecular Weight : 291.69
2-(3,4-Dichlorphenyl)-6-benzoxazolecarboxylic Acid
Catalogue No.:PA 20 3151003
2-Amino-3,5-dichlorobenzoic acid
Catalogue No.:PA 20 3151004
Molecular Formula : C7H5Cl2NO2
Molecular Weight : 206.02
Methyl 3,5-dichlorobenzoate
Catalogue No.:PA 20 3151005
Molecular Formula : C8H6Cl2O2
Molecular Weight : 205.03
Tafamidis Acyl Glucuronide
Catalogue No.:PA 20 3151006
Molecular Formula : C20H15Cl2NO9
Molecular Weight : 484.24
Tafamidis-D3
Catalogue No.:PA STI 089435
Molecular Formula : C14H4D3Cl2NO3
Molecular Weight : 311.13
Methyl 2-(3,5-dichlorophenyl)benzo[d]oxazole-6-carboxylate
Catalogue No.:PA 20 3151007
Molecular Formula : C15H9Cl2NO3
Molecular Weight : 322.14
3-Hydroxy-4-nitrobenzoic Acid
Catalogue No.:PA 20 3151008
Molecular Formula : C7H5NO5
Molecular Weight : 183.12
Methyl 4-(3,5-dichlorobenzamido)-3-hydroxybenzoate
Catalogue No.:PA 20 3151009
Molecular Formula : C15H11Cl2NO4
Molecular Weight : 340.16
4-(3,5-Dichlorobenzamido)-3-((3,5-dichlorobenzoyl)oxy)benzoic Acid
Catalogue No.:PA 20 3151010
Molecular Formula : C21H11Cl4NO5
Molecular Weight : 499.12
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
